Ipca Laboratories Statistics

Total Valuation

Ipca Laboratories has a market cap or net worth of INR 401.49 billion. The enterprise value is 418.65 billion.

Market Cap	401.49B
Enterprise Value	418.65B

Important Dates

The next estimated earnings date is Thursday, February 13, 2025.

Earnings Date	Feb 13, 2025
Ex-Dividend Date	Nov 27, 2024

Share Statistics

Ipca Laboratories has 253.70 million shares outstanding. The number of shares has increased by 0.05% in one year.

Current Share Class	n/a
Shares Outstanding	253.70M
Shares Change (YoY)	+0.05%
Shares Change (QoQ)	-0.02%
Owned by Insiders (%)	8.71%
Owned by Institutions (%)	45.88%
Float	135.44M

Valuation Ratios

The trailing PE ratio is 60.74 and the forward PE ratio is 39.65. Ipca Laboratories's PEG ratio is 1.40.

PE Ratio	60.74
Forward PE	39.65
PS Ratio	4.71
PB Ratio	5.99
P/TBV Ratio	6.21
P/FCF Ratio	44.72
P/OCF Ratio	n/a
PEG Ratio	1.40

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 28.99, with an EV/FCF ratio of 46.63.

EV / Earnings	63.32
EV / Sales	4.91
EV / EBITDA	28.99
EV / EBIT	39.68
EV / FCF	46.63

Financial Position

The company has a current ratio of 2.37, with a Debt / Equity ratio of 0.15.

Current Ratio	2.37
Quick Ratio	1.13
Debt / Equity	0.15
Debt / EBITDA	0.83
Debt / FCF	1.34
Interest Coverage	9.76

Financial Efficiency

Return on equity (ROE) is 8.51% and return on invested capital (ROIC) is 7.01%.

Return on Equity (ROE)	8.51%
Return on Assets (ROA)	5.80%
Return on Capital (ROIC)	7.01%
Revenue Per Employee	4.92M
Profits Per Employee	381,419
Employee Count	17,335
Asset Turnover	0.75
Inventory Turnover	1.23

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +42.87% in the last 52 weeks. The beta is 0.26, so Ipca Laboratories's price volatility has been lower than the market average.

Beta (5Y)	0.26
52-Week Price Change	+42.87%
50-Day Moving Average	1,572.13
200-Day Moving Average	1,367.26
Relative Strength Index (RSI)	54.95
Average Volume (20 Days)	626,428

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ipca Laboratories had revenue of INR 85.34 billion and earned 6.61 billion in profits. Earnings per share was 26.05.

Revenue	85.34B
Gross Profit	54.78B
Operating Income	10.58B
Pretax Income	9.98B
Net Income	6.61B
EBITDA	14.30B
EBIT	10.58B
Earnings Per Share (EPS)	26.05

Full Income Statement

Balance Sheet

The company has 9.03 billion in cash and 12.02 billion in debt, giving a net cash position of -2.99 billion or -11.78 per share.

Cash & Cash Equivalents	9.03B
Total Debt	12.02B
Net Cash	-2.99B
Net Cash Per Share	-11.78
Equity (Book Value)	81.18B
Book Value Per Share	264.24
Working Capital	32.85B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 14.41 billion and capital expenditures -5.44 billion, giving a free cash flow of 8.98 billion.

Operating Cash Flow	14.41B
Capital Expenditures	-5.44B
Free Cash Flow	8.98B
FCF Per Share	35.38

Full Cash Flow Statement

Margins

Gross margin is 64.18%, with operating and profit margins of 12.39% and 7.75%.

Gross Margin	64.18%
Operating Margin	12.39%
Pretax Margin	11.69%
Profit Margin	7.75%
EBITDA Margin	16.76%
EBIT Margin	12.39%
FCF Margin	10.52%

Dividends & Yields

This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 0.25%.

Dividend Per Share	4.00
Dividend Yield	0.25%
Dividend Growth (YoY)	100.00%
Years of Dividend Growth	n/a
Payout Ratio	15.35%
Buyback Yield	-0.05%
Shareholder Yield	0.20%
Earnings Yield	1.65%
FCF Yield	2.24%

Dividend Details

Stock Splits

The last stock split was on January 10, 2022. It was a forward split with a ratio of 2.

Last Split Date	Jan 10, 2022
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a